ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions

Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels

Beauchamp, C., & Fridovich, I. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90370-8 · Cited by 12,892

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062

Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143

GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

Halliwell, B. B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92211-x · Cited by 2,926

Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate

Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534

Cellular defenses against damage from reactive oxygen species

Yu, B. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.1.139 · Cited by 2,382

Localization of neuronal and glial glutamate transporters

Rothstein, J. D., Martin, L. J., Levey, A. I., Dykes‐Hoberg, M., Jin, L., Wu, D. M., Nash, N. R., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,703

Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase

Deng, H., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,479

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471

Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology

Gunes, Z. I., Kan, V. W. Y., Ye, X., & Liebscher, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00573 · Cited by 74

Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen

Wood-Allum, C. A. (2006) · Brain · doi:10.1093/brain/awl118 · Cited by 67

Do oxidatively modified proteins cause ALS?

Valentine, J. S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01080-8 · Cited by 68

Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states

Prudencio, M., & Borchelt, D. R. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-77 · Cited by 63

The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis

Sharp, P. S., Dick, J. R. T., & Greensmith, L. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.069 · Cited by 67

Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord

Calderó, J., Brunet, N., Tarabal, O., Piedrafita, L., Hereu, M., Ayala, V., & Esquerda, J. E. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.034 · Cited by 67

An update on human astrocytes and their role in development and disease

de Majo, M., Koontz, M., Rowitch, D. H., & Ullian, E. M. (2020) · Glia · doi:10.1002/glia.23771 · Cited by 69

Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model

Wengenack, T. M., Holasek, S. S., Montaño, C., Gregor, D. M., Curran, G. L., & Poduslo, J. F. (2004) · Brain Research · doi:10.1016/j.brainres.2004.08.054 · Cited by 67

Heterogeneous astrocytes: Active players in CNS

Hu, X., Yuan, Y., Wang, D., & Su, Z. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.017 · Cited by 73

Non-neuronal induction of immunoproteasome subunits in an ALS model: Possible mediation by cytokines

Puttaparthi, K., & Elliott, J. L. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.027 · Cited by 66

Disrupted Zinc-Binding Sites in Structures of Pathogenic SOD1 Variants D124V and H80R

Seetharaman, S. V., Winkler, D. D., Taylor, A. B., Cao, X., Whitson, L. J., Doucette, P. A., Valentine, J. S., Schirf, V. R., Demeler, B., Carroll, M. C., et al. (2010) · Biochemistry · doi:10.1021/bi100314n · Cited by 66

Unsaturated Fatty Acids Induce Cytotoxic Aggregate Formation of Amyotrophic Lateral Sclerosis-linked Superoxide Dismutase 1 Mutants

Kim, Y., Nakatomi, R., Akagi, T., Hashikawa, T., & Takahashi, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502230200 · Cited by 68

Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1

Nguyen, M. D., Larivière, R., & Julien, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12306 · Cited by 66

The Ψ m depolarization that accompanies mitochondrial Ca 2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals

Nguyen, K. T. V., Garcia-Chacon, L. E., Barrett, J. N., Barrett, E. F., & David, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810934106 · Cited by 65

Collapsin Response Mediator Protein 4a (CRMP4a) Is Upregulated in Motoneurons of Mutant SOD1 Mice and Can Trigger Motoneuron Axonal Degeneration and Cell Death

Duplan, L., Bernard‐Marissal, N., Casseron, W., Dudley, K., Thouvenot, É., Honnorat, J., Rogemond, V., de Bovis, B., Aebischer, P., Marin, P., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5411-09.2010 · Cited by 65

Caenorhabditis elegans as a model system for studying aging-associated neurodegenerative diseases

Pelt, K. M. V., & Truttmann, M. C. (2020) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.05.001 · Cited by 62

Intrinsic properties of lumbar motor neurones in the adult G127insTGGG superoxide dismutase‐1 mutant mouse in vivo: evidence for increased persistent inward currents

Meehan, C. F., Moldovan, M., Marklund, S. L., Graffmo, K. S., Nielsen, J. B., & Hultborn, H. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02188.x · Cited by 64

Mitochondrial Involvement in Amyotrophic Lateral Sclerosis: Trigger or Target?

Bacman, S. R., Bradley, W. G., & Moraes, C. T. (2006) · Molecular Neurobiology · doi:10.1385/mn:33:2:113 · Cited by 66

Genetic Rodent Models of Amyotrophic Lateral Sclerosis

Bosch, L. V. D. (2011) · BioMed Research International · doi:10.1155/2011/348765 · Cited by 70

Mitochondrial Degeneration in Amyotrophic Lateral Sclerosis

Xu, Z., Jung, C., Higgins, C. M. J., Levine, J. B., & Kong, J. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041774.12654.e1 · Cited by 64

Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice

Holasek, S. S., Wengenack, T. M., Kandimalla, K. K., Montaño, C., Gregor, D. M., Curran, G. L., & Poduslo, J. F. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.037 · Cited by 67

The fragmented neuronal Golgi apparatus in amyotrophic lateral sclerosis includes the trans-Golgi-network: functional implications

Stieber, A., Chen, Y. J., Wei, S., Mourelatos, Z., Gonatas, J. O., Okamoto, K., & Gonatas, N. K. (1998) · Acta Neuropathologica · doi:10.1007/s004010050794 · Cited by 64

Gene‐based treatment of motor neuron diseases

Federici, T., & Boulis, N. M. (2005) · Muscle & Nerve · doi:10.1002/mus.20439 · Cited by 64

Altered levels and distribution of microtubule‐associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis

Farah, C. A., Nguyen, M. D., Julien, J., & Leclerc, N. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01505.x · Cited by 64

Autophagy in neuroinflammatory diseases

Muller, S., Brun, S., René, F., Seze, J. D., Loeffler, J., & Jeltsch‐David, H. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.015 · Cited by 66

Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications

Steinruecke, M., Lonergan, R. M., Selvaraj, B. T., Chandran, S., Castro, B. D., & Stavrou, M. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231153281 · Cited by 63

Miro1 deficiency in amyotrophic lateral sclerosis

Zhang, F., Wang, W., Siedlak, S. L., Liu, Y., Liu, J., Jiang, K., Perry, G. L., Zhu, X., & Wang, X. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00100 · Cited by 64

FUS-related proteinopathies: Lessons from animal models

Lanson, N. A., & Pandey, U. B. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.039 · Cited by 66

Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin

Millecamps, S., Robertson, J., Larivière, R., Mallet, J. J., & Julien, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03932.x · Cited by 62

Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice

Nardo, G., Trolese, M. C., Verderio, M., Mariani, A., Paola, M. D., Riva, N., Dina, G., Panini, N., Erba, E., Quattrini, A., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0271-7 · Cited by 62

Defective Neurofilament Transport in Mouse Models of Amyotrophic Lateral Sclerosis: A Review

Rao, M. V., & Nixon, R. A. (2003) · Neurochemical Research · doi:10.1023/a:1023259207015 · Cited by 62

Transgenic Mice with Human Mutant Genes Causing Parkinson's Disease and Amyotrophic Lateral Sclerosis Provide Common Insight into Mechanisms of Motor Neuron Selective Vulnerability to Degeneration

Martin, L. J. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.2.115 · Cited by 61

EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis

Rosenblum, L. T., & Trotti, D. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-55769-4_6 · Cited by 66

Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes

Komine, O., Yamashita, H., Fujimori-Tonou, N., Koike, M., Jin, S., Moriwaki, Y., Endo, F., Watanabe, S., Uematsu, S., Akira, S., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0098-3 · Cited by 66

Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis

Durand, J., Amendola, J., Bories, C., & d’Incamps, B. L. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.014 · Cited by 67

Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice

Fukada, K., Nagano, S., Satoh, M., Tohyama, C., Nakanishi, T., Shimizu, A., Yanagihara, T., & Sakoda, S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01828.x · Cited by 61

From nucleation to widespread propagation: A prion-like concept for ALS

Maniecka, Z., & Polymenidou, M. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.032 · Cited by 65

ALS pathogenesis: Recent insights from genetics and mouse models

Swarup, V., & Julien, J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.006 · Cited by 65

Quantitative Ultrastructural Analysis of a Single Spinal Cord Demyelinated Lesion Predicts Total Lesion Load, Axonal Loss, and Neurological Dysfunction in a Murine Model of Multiple Sclerosis

Sathornsumetee, S., McGavern, D. B., Ure, D., & Rodriguez, M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64650-0 · Cited by 59

The carbonate radical anion-induced covalent aggregation of human copper, zinc superoxide dismutase, and α-synuclein: intermediacy of tryptophan- and tyrosine-derived oxidation products

Zhang, H., Andrekopoulos, C., Joseph, J., Crow, J., & Kalyanaraman, B. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.038 · Cited by 59

S100A6 Overexpression within Astrocytes Associated with Impaired Axons from Both ALS Mouse Model and Human Patients

Hoyaux, D., Boom, A., Bosch, L. V. D., Belot, N., Martin, J., Heizmann, C. W., Robert Kiss, A., & Pochet, R. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.8.736 · Cited by 59

Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum

Shahheydari, H., Ragagnin, A., Walker, A. K., Toth, R. P., Vidal, M., Jagaraj, C. J., Perri, E. R., Konopka, A., Sultana, J. M., & Atkin, J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00119 · Cited by 61

RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells

Maxwell, M. M., Pasinelli, P., Kazantsev, A. G., & Brown, R. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308726100 · Cited by 59

Interaction of Amyotrophic Lateral Sclerosis (ALS)-related Mutant Copper-Zinc Superoxide Dismutase with the Dynein-Dynactin Complex Contributes to Inclusion Formation

Ström, A., Shi, P., Zhang, F., Gál, J., Kilty, R., Hayward, L. J., & Zhu, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800276200 · Cited by 58

Sealing one's fate: control of cell death in neurons

Bergeron, L., & Yuan, J. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80008-1 · Cited by 57

Elevated Cortical Extracellular Fluid Glutamate in Transgenic Mice Expressing Human Mutant (G93A) Cu/Zn Superoxide Dismutase

Alexander, G. M., Deitch, J. S., Seeburger, J. L., Valle, L. D., & Heiman-Patterson, T. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741666.x · Cited by 58

Calcium Ions Promote Superoxide Dismutase 1 (SOD1) Aggregation into Non-fibrillar Amyloid

Leal, S. S., Cardoso, I., Valentine, J. S., & Gomes, C. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470740 · Cited by 60

Glycoursodeoxycholic Acid Reduces Matrix Metalloproteinase-9 and Caspase-9 Activation in a Cellular Model of Superoxide Dismutase-1 Neurodegeneration

Vaz, A. R., Cunha, C., Gomes, C., Schmucki, N., Barbosa, M., & Brites, D. M. T. O. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8731-8 · Cited by 57

Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis

Gianforcaro, A., & Hamadeh, M. J. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12204 · Cited by 61

Amyotrophic Lateral Sclerosis (ALS): Stressed by Dysfunctional Mitochondria-Endoplasmic Reticulum Contacts (MERCs)

Chen, J., Bassot, A., Giuliani, F., & Simmen, T. (2021) · Cells · doi:10.3390/cells10071789 · Cited by 58

Genetic Mapping of a Mouse Modifier Gene That Can Prevent ALS Onset

Kunst, C. B., Messer, L. H., Gordon, J. W., Haines, J. L., & Patterson, D. (2000) · Genomics · doi:10.1006/geno.2000.6379 · Cited by 57

Decrease in Glial Glutamate Transporter Variants and Excitatory Amino Acid Receptor Down-Regulation in a Murine Model of ALS-PDC

Wilson, J. M. B., Khabazian, I., Pow, D. V., Craig, U. K., & Shaw, C. A. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:2:105 · Cited by 57

IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW

de Gois, A. M., de Mendonça, D. M. F., Freire, M. A. M., & dos Santos, J. R. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.012 · Cited by 63

Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis

Raiteri, L., Stigliani, S., Zappettini, S., Mercuri, N. B., Raiteri, M., & Bonanno, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.025 · Cited by 56

Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS

Trías, E., Díaz‐Amarilla, P., Olivera‐Bravo, S., Isasi, E., Drechsel, D. A., Lopez, N. I., Bradford, C. S., Ireton, K. E., Beckman, J. S., & Barbeito, L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00274 · Cited by 62

An orally active anti‐apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease

Sagot, Y., Toni, N., Perrelet, D., Lurot, S., King, B., Rixner, H., Mattenberger, L., Waldmeier, P. C., & Kato, A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703633 · Cited by 56

The Peroxisome Proliferator-activated Receptor γ (PPARγ) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis

Benedusi, V., Martorana, F., Brambilla, L., Maggi, A. C., & Rossi, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366419 · Cited by 58

The Neuroprotective Role of Creatine

Klein, A., & Ferrante, R. J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6486-9_11 · Cited by 56

Induction of motor neuron apoptosis by free 3‐nitro‐ l ‐tyrosine

Peluffo, H., Shacka, J. J., Ricart, K. C., Bisig, C. G., Palma, L. M., Pritsch, O., Kamaid, A., Eiserich, J. P., Crow, J. P., Barbeito, L., et al. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2004.02363.x · Cited by 56

Expression of the low affinity neurotrophin receptor p75 in spinal motoneurons in a transgenic mouse model for amyotrophic lateral sclerosis

Copray, J. C. V. M., Jaarsma, D., Kst, B. M., Bruggeman, R., Mantingh-Otter, I., Brouwer, N., & Boddeke, H. W. G. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00755-8 · Cited by 56

Voltage-Dependent Sodium Channels in Spinal Cord Motor Neurons Display Rapid Recovery From Fast Inactivation in a Mouse Model of Amyotrophic Lateral Sclerosis

Zona, C., Pieri, M., & Carunchio, I. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00566.2006 · Cited by 56

PARP Expression Is Increased in Astrocytes but Decreased in Motor Neurons in the Spinal Cord of Sporadic ALS Patients

Kim, S. H., Henkel-Tigges, J., Beers, D. R., Şengün, İ. Ş., Simpson, E. P., Goodman, J. C., Engelhardt, J. I., Siklós, L., & Appel, S. H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.88 · Cited by 56

Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation

Shibata, N., Nagai, R., Miyata, S., Jono, T., Horiuchi, S., Hirano, A., Kato, S., Sasaki, S., Asayama, K., & Kobayashi, M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900173 · Cited by 56

Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS)

Vanoni, C., Massari, S., Losa, M., Carrega, P., Perego, C., Conforti, L., & Pietrini, G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01411 · Cited by 56

Disease-associated Mutations at Copper Ligand Histidine Residues of Superoxide Dismutase 1 Diminish the Binding of Copper and Compromise Dimer Stability

Wang, J., Caruano-Yzermans, A. L., Rodriguez, A., Scheurmann, J. P., Slunt, H. H., Cao, X., Gitlin, J. D., Hart, P. J., & Borchelt, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604503200 · Cited by 55

Astrocyte signaling and neurodegeneration

Brambilla, L., Martorana, F., & Rossi, D. (2013) · Prion · doi:10.4161/pri.22512 · Cited by 58

Mutant superoxide dismutase 1 overexpression in NSC-34 cells: Effect of trehalose on aggregation, TDP-43 localization and levels of co-expressed glycoproteins

Gomes, C., Escrevente, C., & Costa, J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.065 · Cited by 55

Altered sensorimotor development in a transgenic mouse model of amyotrophic lateral sclerosis

Amendola, J., Verrier, B., Roubertoux, P. L., & Durand, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03745.x · Cited by 55

Pathophysiological Roles of Intracellular Proteases in Neuronal Development and Neurological Diseases

Yagami, T., Yamamoto, Y., & Koma, H. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1277-4 · Cited by 56

Heat‐shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: clues to a possible strategy for treating ALS

Yamashita, H., Kawamata, J., Okawa, K., Kanki, R., Nakamizo, T., Hatayama, T., Yamanaka, K., Takahashi, R., & Shimohama, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04534.x · Cited by 54

Glia-specific autophagy dysfunction in ALS

Strohm, L., & Behrends, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.024 · Cited by 57

Altered blood–brain barrier and blood–spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety

Pan, Y., & Nicolazzo, J. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15802 · Cited by 49

Neuroinflammation and brain infections: Historical context and current perspectives

Bentivoglio, M., Mariotti, R., & Bertini, G. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.09.008 · Cited by 53

Conditional knockout of Mn superoxide dismutase in postnatal motor neurons reveals resistance to mitochondrial generated superoxide radicals

Misawa, H., Nakata, K., Matsuura, J., Moriwaki, Y., Kawashima, K., Shimizu, T., Shirasawa, T., & Takahashi, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.014 · Cited by 53

Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice

Qiu, L., Qiao, T., Beers, M. A., Tan, W., Wang, H., Yang, B., & Xu, Z. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-1 · Cited by 53

Stathmin 1/2-triggered microtubule loss mediates Golgi fragmentation in mutant SOD1 motor neurons

Bellouze, S., Baillat, G., Buttigieg, D., de la Grange, P., Rabouille, C., & Haase, G. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0111-6 · Cited by 54

The Value of Transgenic Models for the Study of Neurodegenerative Diseases

Price, D. L., Wong, P. C., Markowska, A. L., Lee, M. K., THINAKAREN, G., Cleveland, D. W., Sisodia, S. S., & Borchelt, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06920.x · Cited by 52

Motor neuron–immune interactions: the vicious circle of ALS

Barbeito, A. G., Mesci, P., & Boillée, S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0429-0 · Cited by 57

Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis

Watanabe, S., Nagano, S., Duce, J. A., Kiaei, M., Li, Q.-X., Tucker, S. M., Tiwari, A., Brown, R. H., Beal, M. F., Hayward, L. J., et al. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.02.004 · Cited by 52

Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis

McCrate, M., & Kaspar, B. K. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8030-5 · Cited by 52

A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations

Abrahamsen, G., Fan, Y., Matigian, N., Wali, G., Bellette, B., Sutharsan, R., Raju, J., Wood, S. A., Veivers, D., Sue, C. M., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010884 · Cited by 56

Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis

Tovar‐y‐Romo, L. B., Santa-Cruz, L. D., & Tapia, R. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-31 · Cited by 52

The Copper Metabolism MURR1 Domain Protein 1 (COMMD1) Modulates the Aggregation of Misfolded Protein Species in a Client-Specific Manner

Vonk, W. I. M., Kakkar, V., Bartuzi, P., Jaarsma, D., Berger, R., Hofker, M. H., Klomp, L. W. J., Wijmenga, C., Kampinga, H. H., & van de Sluis, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092408 · Cited by 52

Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients

Shobha, K., Vijayalakshmi, K., Alladi, P. A., Nalini, A., Sathyaprabha, T. N., & Raju, T. R. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.12.004 · Cited by 52

Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis

Zhang, J., Ito, H., Wate, R., Ohnishi, S., Nakano, S., & Kusaka, H. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0130-4 · Cited by 52

Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View

Sanghai, N., & Tranmer, G. K. (2023) · Cells · doi:10.3390/cells12182318 · Cited by 60

Advances in stem cell research for Amyotrophic Lateral Sclerosis

Papadeas, S. T., & Maragakis, N. J. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.09.003 · Cited by 51

Emerging drugs for amyotrophic lateral sclerosis

Habib, A. A., & Mitsumoto, H. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.604312 · Cited by 52

Palmitoylation of Superoxide Dismutase 1 (SOD1) Is Increased for Familial Amyotrophic Lateral Sclerosis-linked SOD1 Mutants

Antinone, S. E., Ghadge, G. D., Lam, T. T., Wang, L., Roos, R. P., & Green, W. N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.487231 · Cited by 51

Oxygen glucose deprivation-induced astrocyte dysfunction provokes neuronal death through oxidative stress.

Gouix, E., Buisson, A., Nieoullon, A., Goff, L. K.-L., Tauskela, J., Blondeau, N., & Had‐Aissouni, L. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.002 · Cited by 53

Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane

Ahtoniemi, T., Jaronen, M., Keksa-Goldsteine, V., Goldsteins, G., & Koıstınaho, J. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.010 · Cited by 51

Motor neuron disease: Classification and nomenclature

Swash, M. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515403 · Cited by 51

In Vitro Modeling of Nerve–Muscle Connectivity in a Compartmentalized Tissue Culture Device

Machado, C. B., Pluchon, P., Harley, P., Rigby, M., Sabater, V. G., Stevenson, D. C., Hynes, S., Lowe, A., Burrone, J., Viasnoff, V., et al. (2019) · Advanced Biosystems · doi:10.1002/adbi.201800307 · Cited by 55

Inhibition of Chaperone Activity Is a Shared Property of Several Cu,Zn-Superoxide Dismutase Mutants That Cause Amyotrophic Lateral Sclerosis

Tummala, H., Jung, C., Tiwari, A., Higgins, C. M. J., Hayward, L. J., & Xu, Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501705200 · Cited by 51

Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation

Shibata, N., Hirano, A., Hedley-Whyte, T. E., Canto, M. C. D., Nagai, R., Uchida, K., Horiuchi, S., Kawaguchi, M., Yamamoto, T., & Kobayashi, M. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0537-5 · Cited by 51

Early glial responses in murine models of multiple sclerosis

Ayers, M. M., Hazelwood, L. J., Catmull, D. V., Wang, D., McKormack, Q., Bernard, C. C. A., & Orian, J. M. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.08.018 · Cited by 51

Impaired post‐translational folding of familial ALS‐linked Cu, Zn superoxide dismutase mutants

Bruns, C. K., & Kopito, R. R. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601528 · Cited by 51

Regulation of Glutamate, GABA and Dopamine Transporter Uptake, Surface Mobility and Expression

Ryan, R. M., Ingram, S., & Scimemi, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.670346 · Cited by 54

Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential

You, J., Youssef, M., Santos, J. R., Lee, J., & Park, J. (2023) · Biology · doi:10.3390/biology12101307 · Cited by 60

Pyrimidine-2,4,6-trione Derivatives and Their Inhibition of Mutant SOD1-Dependent Protein Aggregation. Toward a Treatment for Amyotrophic Lateral Sclerosis

Xia, G., Benmohamed, R., Kim, J., Arvanites, A. C., Morimoto, R. I., Ferrante, R. J., Kirsch, D. R., & Silverman, R. B. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101549k · Cited by 50

Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice

Wang, L., Gutmann, D. H., & Roos, R. P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq463 · Cited by 214

SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis

Wallis, N., Lau, C. L., Farg, M. A., Atkin, J. D., Beart, P. M., & O’Shea, R. D. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2385-7 · Cited by 14

Issue Cover (October 2015)

(2015) · Journal of Neurochemistry · doi:10.1111/jnc.12905

Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration

Gong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., & Elliott, J. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00660.2000 · Cited by 387

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Swami, M. (2011) · Nature Medicine · doi:10.1038/nm.2484 · Cited by 33